The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Open accessAbstract
Radiotherapy plays a central part in curing cancer. For decades, most research on improving treatment outcomes has focused on modulating radiation-induced biological effects on cancer cells. Recently, we have better understood that components within the tumour microenvironment have pivotal roles in determining treatment outcomes. In this Review, we describe vascular, stromal and immunological changes that are induced in the tumour microenvironment by irradiation and discuss how these changes may promote radioresistance and tumour recurrence. We also highlight how this knowledge is guiding the development of new treatment paradigms in which biologically targeted agents will be combined with radiotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Generation of intratumoral O2 is also feasible to improve the efficacy of radiotherapy by using bioactive albumin-MnO2 nanoparticles [94].”
From Hypoxia Signaling in Cancer: From Basics to Clinical Practice (2021) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedMMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells
Badiga, A. V., Chetty, C., Kesanakurti, D., Are, D., Gujrati, M., Klopfenstein, J. D., Dinh, D. H., & Rao, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020614 · Cited by 110
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,005
Semiconducting Polymer Nanoparticles as Activatable Nanomedicines for Combinational Phototherapy
Xu, M., Zhang, C., Zeng, Z., & Pu, K. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c00695 · Cited by 35
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicity
Tuomela, K., Mukherjee, D., Ambrose, A. R., Harikrishnan, A., Mole, H., Hurlstone, A. F. L., Önfelt, B., Honeychurch, J., & Davis, D. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111900119 · Cited by 34
Sheng, Y., Zhang, B., Xing, B., Liu, Z., Chang, Y., Wu, G., & Zhao, Y. (2023) · Cancers · doi:10.3390/cancers15051620 · Cited by 33
“IR triggers treatment responses in components within the tumor microenvironment (TME) other than cancer cells [7].”
BackgroundWang, L., Si, W., Yu, X., Piffkó, A., Dou, X., Ding, X., Bugno, J., Yang, K., Wen, C., Zhang, L., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci172919 · Cited by 34
Gutierrez, N. M. C., Clainche, T. L., Bulin, A., Leo, S., Kadri, M., Abdelhamid, A. G. A., Pujol‐Solé, N., Obaid, G., Hograindleur, M., Gardette, V., et al. (2024) · Advanced Materials · doi:10.1002/adma.202404605 · Cited by 33
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Lv, K., & He, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00233-8 · Cited by 36
Microvascular head and neck reconstruction after (chemo)radiation
Paderno, A., Piazza, C., Bresciani, L., Vella, R., & Nicolai, P. (2016) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000243 · Cited by 33
“These processes span the entire timescale of wound reparation, and this continued interference with physiologic healing control leads to excessive deposition of extracellular matrix and collagen [25,26].”
BackgroundGerken, L. R. H., Keevend, K., Zhang, Y., Starsich, F. H. L., Eberhardt, C., Panzarasa, G., Matter, M. T., Wichser, A., Boss, A., Neels, A., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20334 · Cited by 33
Reoxygenation during radiotherapy in intermediate-risk prostate cancer
Supiot, S., Rousseau, C., Dore, M., Rest, C. C. L., Kandel-Aznar, C., Potiron, V. A., Guerif, S. G., Paris, F., Ferrer, L., Campion, L., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.12.022 · Cited by 33
Zheng, X., Cui, L., Chen, M., Soto, L. A. C., Graves, E. E., & Rao, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0530 · Cited by 33
“the short-term dramatic change of tumor hypoxia in the first 24 h after each fraction monitored by ratiometric imaging can reflect the combined effects of multiple factors on oxygenation such as radiation-induced direct and indirect cell death, changes in blood perfusion, acute and chronic vascular damage, change of i…”
BackgroundResultInfluentialChicas-Sett, R., Zafra, J., Morales-Orue, I., Castilla-Martinez, J., Francés, M. Á. B., González-Rodríguez, E., Rodríguez‐Abreu, D., & Couñago, F. (2020) · Cancers · doi:10.3390/cancers12082178 · Cited by 33
“However, it must be noted that RT also induces the activation of immunosuppressive molecules, such as transforming growth factor beta (TGF-β), which is a critical factor for regulatory T cell (Treg) differentiation [37].”
BackgroundUltrathin gold nanowires to enhance radiation therapy
Bai, L., Jiang, F., Wang, R., Lee, C., Wang, H., Zhang, W., Jiang, W., Li, D., Ji, B., Li, Z., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00678-3 · Cited by 33
Y2O3 Nanoparticles and X-ray Radiation-Induced Effects in Melanoma Cells
Porosnicu, I., Butnaru, C. M., Tiseanu, I., Stancu, E., Munteanu, C. V. A., Bita, B. I., Duliu, O. G., & Sima, F. (2021) · Molecules · doi:10.3390/molecules26113403 · Cited by 33
“Nevertheless, recurrence is often encountered and radioresistance may appear, all these are reflected in a low survival rates for cancer patients [43].”
BackgroundRosati, D., & Giordano, A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114811 · Cited by 36
Emerging nanozymes for potentiating radiotherapy and radiation protection
Chong, Y., Ning, J., Min, S., Ye, J., & Ge, C. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.03.054 · Cited by 33
Novel strategies for tumor radiosensitization mediated by multifunctional gold-based nanomaterials
Wang, Z., Ren, X., Wang, D., Guan, L., Li, X., Zhao, Y., Liu, A., He, L., Wang, T., Zvyagin, A. V., et al. (2022) · Biomaterials Science · doi:10.1039/d2bm01496c · Cited by 33
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors
Sun, W., Chu, C., Li, S., Ma, X., Liu, P., Chen, S., & Chen, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114643 · Cited by 33
Strategies for Heating Up Cold Tumors to Boost Immunotherapies
Zabransky, D. J., Yarchoan, M. M., & Jaffee, E. M. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-040258 · Cited by 34
Mao, L., Zhou, J., Xiao, Y., Yang, Q., Yang, S., Wang, S., Wu, Z., Xiong, H., Yu, H., & Sun, Z. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02230-0 · Cited by 34
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications
Bhat, V., Pellizzari, S., Allan, A. L., Wong, E., Lock, M., Brackstone, M., Lohmann, A. E., Cescon, D. W., & Parsyan, A. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103566 · Cited by 31
Tumor acidic environment directs nanoparticle impacts on cancer cells
Ghaemi, B., & Hajipour, M. J. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.12.019 · Cited by 33
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance
Gao, Q., Zhan, Y., Sun, L., & Zhu, W. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10593-3 · Cited by 34
“Complex biological interactions between the tumor matrix and growth factors promote the occurrence, development, metastasis, and drug resistance of tumors [40, 52].”
BackgroundHuang, N.-H., Tang, X., Meng, W., Lai, Y.-H., Zhou, X., Yu, X.-Z., Zhang, W., & Chen, J.-X. (2023) · ACS Nano · doi:10.1021/acsnano.3c04189 · Cited by 33
Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer
Zhao, L., Li, M., Shen, C., Luo, Y., Hou, X., Qi, Y., Huang, Z., Li, W., Gao, L., Wu, M. C., et al. (2024) · Research · doi:10.34133/research.0429 · Cited by 36
“Under the condition of radiation exposure, TME has changed in many aspects, such as blood vessels, stroma, increased hypoxia state, and immunity, which are also correlated with radioresistance and tumor recurrence [96].”
BackgroundIntricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation
Pinto, A. T., Pinto, M. L., Velho, S., Pinto, M. T., Cardoso, A. P., Figueira, R., Monteiro, A., Marques, M., Seruca, R., Barbosa, M. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160891 · Cited by 32
The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma
Jia, H., Ren, W., Feng, Y., Wei, T., Guo, M., Guo, J., Zhao, J., Song, X., Wang, M., Zhao, T., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4473 · Cited by 32
“A large body of evidence has indicated that the tumour microenvironment may prompt tumour development, progression and immune evasion (63,64).”
Huang, C., Zheng, J., Ma, D., Liu, N., Zhu, C., Li, J., & Yang, R. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01805g · Cited by 32
Kim, W. R., Han, Y. D., & Min, B. S. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6828-4 · Cited by 32
Zhang, Y., Liu, J., Yu, Y. H., Chen, S., Huang, F., Yang, C., Chang, J., Yang, L., Fan, S., & Liu, J. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102241 · Cited by 32
Zou, R., Gong, Q., Shi, Z., Zheng, J., Xing, J., Chuang, L. I. U., Jiang, Z., & Wu, A. (2020) · Nanoscale · doi:10.1039/d0nr02580a · Cited by 31
Evidence for hypoxia increasing the tempo of evolution in glioblastoma
Grimes, D. R., Jansen, M., Macaulay, R. J. B., Scott, J. G., & Basanta, D. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-1021-5 · Cited by 32
MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis
Zhou, K.-Q., Wei, Y., Li, X., & Yang, X. L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119798 · Cited by 32
Radiomics-guided radiation therapy: opportunities and challenges
Abdollahi, H., Chin, E., Clark, H., Hyde, D. E., Thomas, S., Wu, J., Uribe, C., & Rahmim, A. (2022) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ac6fab · Cited by 32
Shao, L., Zhu, B.-S., XING, C.-G., Yang, X., YOUNG, W., & Cao, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4820 · Cited by 32
“Previous studies have demonstrated that TAMs secrete PDGF, IL-1 and -6 to aid tumor cell survival and reduce tumor radiosensitivity (15,16,25).”
Du, J., Kageyama, S., Yamashita, R., Tanaka, K., Okumura, M., Motegi, A., Hojo, H., Nakamura, M., Hirata, H., Sunakawa, H., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05080-x · Cited by 33
“It has been reported that RT induces the upregulation of type I IFN, MHC class I and PD-L1 (CD274) in cancer cells, and several immune cells, such as CD8 + T cells, dendritic cells (DCs) and M1 macrophages, are attracted to tissues after RT 2 .”
Wang, Y., Wang, L., Li, T., Ouyang, M., Xiong, H., & Zhou, D. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.028 · Cited by 31
“The primary limitation of radio-immunotherapy lies in its inability to induce sufficient ICD effect, which is crucial for triggering effective immune responses 8,46 .”
BackgroundT cells in cancer: mechanistic insights and therapeutic advances
Pu, J., Liu, T., Zhou, Y., Chen, M., Fu, X., Wan, Y., Wang, J., Chen, B., Sharma, A., Lukacs‐Kornek, V., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00807-w · Cited by 33
“Furthermore, radiation therapy modifies the TME by promoting the release of TAAs, upregulating MHC molecules, and triggering the activation of various immune cells [326–328].”
Bioluminescent Probe for Tumor Hypoxia Detection via CYP450 Reductase in Living Animals
Gao, Y., Lin, Y., Liu, T., Chen, H., Yang, X., Tian, C., Du, L., & Li, M. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03597 · Cited by 31
Moreau, M., Yasmin‐Karim, S., Kunjachan, S., Sinha, N., Gremse, F., Kumar, R., Chow, K. F., & Ngwa, W. F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00056 · Cited by 31
“This may be because, implantation of the SRBs can cause inflammation or render cells to release cellular danger-associated molecular patterns (DAMPs) and cytokines that enhance traffic of immune cells (26).”
BackgroundLight-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy
Sun, C., Zhang, B., & Zhou, J.-Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01115c · Cited by 31
Abdali, M. H., Afshar, S., Pashaki, A. S., Dastan, D., Gholami, M. H., Mahmoudi, R., & Saidijam, M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115152 · Cited by 31
Scherr, A., Jassowicz, A., Pató, A., Elßner, C., Ismail, L., Schmitt, N., Hoffmeister‐Wittmann, P., Neukirch, L., Gdynia, G., Goeppert, B. F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031099 · Cited by 34
“This was assessed by calreticulin surface expression after siRNA transfection, with oxaliplatin serving as a positive control for the assessment of ICD [17].”
MethodCurrent and Future Perspectives of the Use of Organoids in Radiobiology
Nagle, P. W., & Coppes, R. P. (2020) · Cells · doi:10.3390/cells9122649 · Cited by 32
“Radiotherapy (either alone or in combination with surgery and/or chemotherapy) is used to treat over half of all cancer patients, with a curative intent in the majority of these cases [2,3].”
BackgroundComprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer
Yan, S.-B., Fang, J., Chen, Y., Xie, Y., Zhang, S., Zhu, X., & Fang, F. (2020) · BMC Cancer · doi:10.1186/s12885-020-07695-3 · Cited by 30
Radiotherapy assisted with biomaterials to trigger antitumor immunity
Yu, X., Ma, H., Xu, G., & Liu, Z. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.02.049 · Cited by 31
Wang, J., Li, J., Wu, Y., Xu, X., Qian, X., Lei, Y., Liu, H., Zhang, Z., & Li, Y. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03227 · Cited by 31
3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research
Antonelli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310620 · Cited by 34
“Furthermore, it would be important to note that there are reports that radiotherapy can cause numerous changes in stromal cells which may be a contributing cause of undesirable effects such as tumor growth, invasion and resistance to treatments [69].”
BackgroundPassive Targeting and the Enhanced Permeability and Retention (EPR) Effect
Onzi, G. R., Guterres, S. S., Pohlmann, A. R., & Frank, L. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_108-1 · Cited by 33
Bi 2– x Mn x O 3 Nanospheres Engaged Radiotherapy with Amplifying DNA Damage
Chen, B., Xiao, L., Wang, W., Xu, L., Jiang, Y., Zhang, G., Liu, L., Li, X., Yu, Y., & Qian, H. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c06838 · Cited by 30
Wang, Y., Williams, G. R., Zheng, Y., Guo, H., Chen, S., Ren, R., Wang, T., Xia, J., & Zhu, L. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.07.146 · Cited by 30
RetractedZhang, Q., Wang, X., Zhao, Y., Cheng, Z., Fang, D., Liu, Y., Tian, G., Li, M., & Luo, Z. Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c08907 · Cited by 31
He, J., Yan, Y., Zhang, J., Wei, Z., Li, H., & Xing, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298683 · Cited by 31
“It has shown anti-tumor activity in various preclinical models of solid tumors (9, 39 – 42), including ovarian cancer, glioblastoma, pancreatic cancer, breast cancer, lung cancer, and others.”
BackgroundHajfathalian, M., Mossburg, K. J., Radaic, A., Woo, K. E., Jonnalagadda, P., Kapila, Y. L., Bollyky, P. L., & Cormode, D. P. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1959 · Cited by 31
Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review
Yang, X., Yasinjan, F., Sun, S., Yang, J., Du, Y., Zhang, H., Liang, Y., Geng, H., Wang, Y., Sun, J., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102386 · Cited by 30
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy
Zhang, Y., Liu, Y., Li, T., Yang, X., Lang, S., Pei, P., Pei, H., Chang, L., Hu, L. T., Liu, T., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.076 · Cited by 30
Tian, Y., Wang, L., Chen, R., Miao, Y., Liu, Y., Huang, W., Fang, L., Liu, S., Luo, J.-W., Sun, X., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202500645 · Cited by 30
Hlavata, Z., Solinas, C., Silva, P. D., Porcu, M., Saba, L., Willard-Gallo, K. E., & Scartozzi, M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0556-3 · Cited by 30
Liu, T., Yang, Y., Chiang, W., Hung, C.-K., Tsai, Y.-C., Chiang, C., Lo, C.-L., & Chiu, H. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00942 · Cited by 30
Tumor Microenvironment – Selective Pressures Boosting Cancer Progression
Nunes, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_2 · Cited by 33
Zhang, L., Li, M., Zhou, Q., Dang, M., Tang, Y., Wang, S., Fu, J., Teng, Z., & Lu, G. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.003 · Cited by 30
Multifunctional Hypoxia-Involved Gene Silencing Nanoplatform for Sensitizing Photochemotherapy
Wang, H., Chen, Y., Shang, J., Wang, H., Pan, M., Liu, X., Zhou, X., & Wang, F. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c08315 · Cited by 30
Yao, G., Tang, J. P., Yang, X., Zhao, Y., Zhou, R., Meng, R., Zhang, S., Dong, X., Zhang, T., Yang, K., et al. (2020) · Theranostics · doi:10.7150/thno.42578 · Cited by 29
“The intrinsic radioresistance of lung cancer cells limits the clinical efficacy of radiotherapy, leading to tumor recurrence and distant metastasis [3].”
BackgroundMcNabb, E., Al‐Mahrouki, A., Law, N., McKay, S., Tarapacki, C. M., Hussein, F., & Czarnota, G. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239456 · Cited by 30
Dong, J., Gao, H.-L., Wang, W., Yu, X., & Liu, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188484 · Cited by 30
Poon, D., Tay, L. M., Ho, D., Chua, M. L. K., Chow, E. K., & Yeo, E. L. L. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.019 · Cited by 31
The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication
Dou, S., Li, R., He, N., Zhang, M., Jiang, W. H., Ye, L., Yang, Y., Zhao, G., Yang, Y., Jiang, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.618367 · Cited by 29
Immunobiology of cancer-associated fibroblasts in the context of radiotherapy
Hellevik, T., Berzaghi, R., Lode, K., Islam, A., & Martínez-Zubiaurre, I. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03112-w · Cited by 32
The effect of hypoxia on PD-L1 expression in bladder cancer
Smith, V., Mukherjee, D., Lunj, S., Choudhury, A., Hoskin, P., West, C., & Illidge, T. (2021) · BMC Cancer · doi:10.1186/s12885-021-09009-7 · Cited by 30
“Both an immunosuppressive TME and hypoxia contribute to the failure of radiotherapy [9, 10].”
BackgroundLi, Y., & Li, X. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02831-w · Cited by 30
“Nevertheless, because of innate or acquired resistance to radiation therapy, radioresistance remains the main clinical problem for TNBC, which may cause treatment failure, recurrence and even death [5, 6].”
BackgroundExploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity
Kunika, Frey, N., & Rangrez, A. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087261 · Cited by 32
“Types of bacteria in cardiac diseases: Recent studies have highlighted a possible contribution of the gut microbiome to CVD. CVDs is linked to a higher Firmicutes/Bacteroidetes (F/B) proportion.”
BackgroundRadiotherapy combined with nano-biomaterials for cancer radio-immunotherapy
Dong, Q., Xue, T., Yan, H., Liu, F., Liu, R., Zhang, K., Chong, Y., Du, J., & Zhang, H. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02152-2 · Cited by 31
Cui, L., Zhao, Y., Pan, Y., Zheng, X., Shao, D., Jia, Y., He, K., Li, K., & Chen, L. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s150456 · Cited by 30
“Researchers have investigated the mechanism of cancer recurrence from various aspects, including apoptosis-related genes, chromosome aberration, angiogenesis, the cancer microenvironment, the immune systemancer stem cells.(22) Cytotoxin chemotherapy is a common type of chemotherapy and is widely used in systemic thera…”
Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth
Duan, C., Yang, R., Yuan, L., Engelbach, J. A., Tsien, C. I., Rich, K. M., Dahiya, S. M., Johanns, T. M., Ackerman, J. J. H., & Garbow, J. R. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.08.033 · Cited by 30
“Although substantial work has emphasized the immediate radiobiologic damage to the tumor and surrounding tissues (8–10), delayed, late, radiation-induced alterations to the brain microenvironment (BME) appear to play an important role in the pattern of tumor regrowth (11).”
BackgroundWounding triggers invasive progression in human basal cell carcinomaPreprint
Yerly, L., Andreatta, M., Garnica, J., Nardin, C., Domizio, J. D., Aubin, F., Gilliet, M. F., Carmona, S. J., & Kuonen, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.31.596823 · Cited by 30
Benkhaled, S., Peters, C., Jullian, N., Arsenijevic, T., Navez, J., Gestel, D. V., Moretti, L., Laethem, J. V., & Bouchart, C. (2023) · Cancers · doi:10.3390/cancers15030768 · Cited by 29
Liu, J., Liu, C., Tang, J., Chen, Q., Yu, Y., Dong, Y., Hao, J., & Wu, W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02196-4 · Cited by 29
“Reducing tumor hypoxia can effectively reduce tumor resistance to RT [13].”
BackgroundZhou, Z., Zhang, B., Deng, Y., Deng, S., Li, J., Wei, W., Wang, Y., Wang, J., Feng, Z., Che, M., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02959-3 · Cited by 33
“Radioresistance can be caused by various mechanisms, including DNA damage repair [32, 33], tumor microenvironment remodeling [34], cell senescence [35, 36], immune response [34, 37], and metabolic reprogramming [38].”
BackgroundNatural Guardians: Natural Compounds as Radioprotectors in Cancer Therapy
Stasiłowicz-Krzemień, A., Gościniak, A., Formanowicz, D., & Cielecka‐Piontek, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136937 · Cited by 37
“Radiation therapy can lead to extensive damage to the body, including the activation of the immune response and the occurrence of widespread inflammation [59].”
BackgroundAmit, U., Uslu, U., Verginadis, I. I., Kim, M. M., Motlagh, S. A. O., Diffenderfer, E. S., Assenmacher, C., Bicher, S., Atoche, S. J., Ben‐Josef, E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403002121 · Cited by 29
“Beyond its classical role in eradicating cancer cells, a paradigm shift acknowledges that RT profoundly influences the tumor microenvironment (TME) and the immune system (20).”
Lu, D., Li, W., Tan, J., Li, Y., Mao, W., Zheng, Y., Yang, M., Wang, J., Wang, W., Wang, S., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c09825 · Cited by 29
Lin, Y., Chen, C., Nguyen, D. L. T., Su, H., Lin, K., Chen, H., Hu, Y., Lai, P., & Sung, H. (2020) · Small · doi:10.1002/smll.202000655 · Cited by 29
Oncometabolites and the response to radiotherapy
Xiang, K., Jendrossek, V., & Matschke, J. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01638-9 · Cited by 30
Neshasteh‐Riz, A., Amini, S. M., Mohammadi, A., Mahdavi, S. R., Mahabadi, V. P., & Akbari, A. (2020) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6254/abb8c7 · Cited by 29
Li, B., Jiang, C., Pang, L., Zou, B., Ding, M., Sun, X., Yu, J., & Wang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627197 · Cited by 30
Liu, Z., Lu, X., Wen, L., You, C., Jin, X., & Liu, J. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001213 · Cited by 29
Alfonso, J. C. L., Grass, G. D., Welsh, E. A., Ahmed, K. A., Teer, J. K., Pilon‐Thomas, S., Harrison, L. B., Cleveland, J. L., Mulé, J. J., Eschrich, S. A., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.09.003 · Cited by 29
Li, W., Li, B., Wu, B., Tian, B., Chen, X., Wang, C., Hong, W., & Peng, J. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c05748 · Cited by 29
Cancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate Tumor
Zhao, Y., Lu, T., Song, Y., Wen, Y., Deng, Z., Fan, J., Zhao, M., Zhao, R., Luo, Y., xie, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202204177 · Cited by 29
Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies
Fang, H., Wang, X., Lan, X., & Jiang, D. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230002 · Cited by 29
Chen, Y., Meng, W., Chen, M., Zhang, L., Chen, M.-W., Chen, X., Peng, J., Huang, N.-H., Zhang, W., & Chen, J.-X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01736b · Cited by 29
Bosma, S. C. J., Hoogstraat, M., van der Leij, F., de Maaker, M., Wesseling, J., Lips, E. H., Loo, C. E., Rutgers, E. J. T., Elkhuizen, P. H. M., Bartelink, H. G. M. M., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.09.002 · Cited by 29
Kulcenty, K. I., Piotrowski, I., Zaleska, K., Wichtowski, M., Wróblewska, J. P., Murawa, D., & Suchorska, W. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-44412-y · Cited by 29
Zhang, P.-F., & Xie, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362133 · Cited by 29
“Moreover, radiotherapy can also induce local immunogenic effects and stimulate the innate immune system (95, 96).”
BackgroundNanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy
Xu, X., Zhang, Y., Meng, C., Zheng, W., Wang, L., Zhao, C., & Luo, F. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00769g · Cited by 28
Blockade of CD73 potentiates radiotherapy antitumor immunity and abscopal effects via STING pathway
An, R., Wu, C., Tang, C., Zhang, C., Han, F., Xu, Z., Zou, Y., Wang, J., Yuan, Z., Jiang, S., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02171-4 · Cited by 28
“Anti-mouse STING antibodies (clone H151) were acquired through Selleck.”
Li, G., Lin, H., Tian, R., Zhao, P., Huang, Y., Pang, X., Zhao, L., & Cao, B. (2018) · Journal of Cancer · doi:10.7150/jca.25370 · Cited by 27
“Radiotherapy is widely used therapeutic medical treatment for up to 50% of all cancer patients worldwide [1].”
BackgroundYu, P., Han, X., Yin, L., Hui, K., Guo, Y., Yuan, A., Hu, Y., & Wu, J. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900031 · Cited by 28
A nanogel sensor for colorimetric fluorescence measurement of ionizing radiation doses
Li, W., Nie, J., Hu, R., Zhao, R. J., Zhu, W., Chen, X., Li, D., Wang, L., & Hu, L. (2019) · Chemical Communications · doi:10.1039/c9cc03680f · Cited by 28
Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy
Tu, J., Tu, K., Xu, H., Wang, L., Yuan, X., Qin, X., Kong, L., Chu, Q., & Zhang, Z. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.03.003 · Cited by 29
Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer
Galiana, I. L., Francés, M. Á. B., Cortés, R. C., Pujol-Canadell, M., Antón, S. C., Martinez, E., Laplana, M., Pérez, H., Plà, M. J., Navarro-Martín, A., et al. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa083 · Cited by 28
“transforming growth factor (TGF) β and immnusopressive cells, such as myeloid-derived suppressor cells (MDSC) and regulatory T (Treg) cells, are part of theses immune inhibitory effects [11].”
Background
Metadata
- Authors
- Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J.
- Affiliations
- Institute of Cancer Research (GB)
- Corresponding author
- Barker, Holly E.
- Venue
- Nature Reviews Cancer
- Published
- 2015-06-24
- Volume
- 15
- Issue
- 7
- Pages
- 409-425
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4896389
- OpenAlex
- W1912124796
- Cited by
- 2,144
- References
- 200
- Citations by year
- 2026: 181 · 2025: 215 · 2024: 246 · 2023: 242 · 2022: 249 · 2021: 256 · 2020: 230 · 2019: 175 · 2018: 161 · 2017: 119 · 2016: 63 · 2015: 7
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-07-24)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK (C46 ⁄ A10588, C7224/A13407, A13407, 13407)
- National Institute for Health and Care Research (CL-2014-22-003)
- Rosetrees Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- tumor microenvironment, radioresistance (biology), radiotherapy, tumor stroma, tumor recurrence, vascular changes, immunological changes, combination therapy, molecularly targeted agents
- MeSH terms
- Animals, Fibroblasts, Humans, Immune Tolerance, Neoplasm Recurrence, Local, Neoplasms, Radiation Tolerance, Cell Hypoxia, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
